Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact

The Return Of Mesothelioma Clinical Trials

by Brayton Purcell LLP | Sep 8, 2020 | Mesothelioma

pill packages in silver packages

Clinical trials are a vital form of research where tests are conducted and evaluated based on how subjects react to a new, potentially life-saving drug or treatment. The process is often mandated by the Food and Drug Administration (FDA) before a product is introduced to the public. Starting with the discovery phase, trials can last up to six to seven years based on the time each subsequent phase requires.

Testing Grinds To A Halt

Earlier this year, the world seemingly stopped when the COVID-19 pandemic shuttered people in their homes and closed businesses in all types of industries. Patients suffering from mesothelioma saw trials grind to a halt, as did enrollment into these studies. Those who already signed up for tests were forced to wait.

With businesses in various industries starting to relaunch operations, treatment centers are resuming clinical trials while others are removing limitations that existed prior to the pandemic. Participants can once again have access to experimental treatments not yet approved by the FDA.

Innovation Leads The Way

The National Cancer Institute (NCI) is also helping medical professionals implement safety measures while encouraging review boards and trial sponsors to be more flexible on test and assessment timing for mesothelioma patients.

If anything good can come out of a pandemic is the change, if not modernization of clinical trial logistics that include:

  • Increasing accessibility of travel
  • Shipping medication to patients’ homes
  • Virtual study visits
  • Blood tests in less-crowded environments

The implementation of telemedicine and online appointments combined with reduced geographical restrictions can ease the challenges patients face, not to mention the fear of disqualification from what could be life-saving experimental treatments.

For those suffering from a deadly form of cancer where a cure has been elusive, their lives literally depend on it.

Recent Posts

  • Who is Most at Risk of Mesothelioma?
  • Boiler Room Workers and Asbestos Exposure
  • Mitigating the financial impact of mesothelioma treatments
  • The EPA’s difficulty with data disclosure
  • Judge orders EPA to close loopholes on asbestos-related reporting

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us